All Resources
App Note
Revolutionizing Adoptive Cell Therapy Development with Bruker’s Beacon® Platform

Bruker’s optofluidic Beacon technology provides deterministic control over individual cells to perform thousands of experiments with single cells in parallel for unique and powerful insights into cellular functionality.

What's Inside

In this App Note we discuss:

Adoptive Cell Therapy Development Challenges and Opportunities
Advanced Single-Cell Functional Characterization with the Beacon Platform
The Adoptive Cell Therapy Development Timeline
Get the App Note